Post-Dobbs Abortion Pill Surge Highlights Stakes of Looming Supreme Court Case – By Julia Conley (Common Dreams) / March 20, 2024
“Next week as we hear oral arguments in the FDA v. Alliance for Hippocratic Medicine case, remember who will be impacted,” said one group.
As abortion bans and restrictions have taken hold in at least 21 states since the right-wing majority on the U.S. Supreme Court voted to overturn Roe v. Wade nearly two years ago, Americans’ reliance on medication abortion became increasingly clear—with the use of abortion pills reported in 63% of all abortions that took place within the formal healthcare system in 2023.
Medication abortion represented 53% of all abortions in the U.S. in 2020, signifying a substantial increase since the court ruled in Dobbs v. Jackson Women’s Health Organization.
The Guttmacher Institute released the results of its Monthly Abortion Provision Study on Tuesday, a week before the Supreme Court is set to hear oral arguments in Food and Drug Administration, et al., Applicants v. Alliance For Hippocratic Medicine, et al., a case brought by the right-wing Alliance Defending Freedom on behalf of anti-abortion doctors.
CONTINUE > https://www.commondreams.org/news/abortion-pill-supreme-court
